Proteins and Peptides

25 Jul 2016 Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Trial With KEYTRUDA
21 Jul 2016 Mylan and Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency
20 Jul 2016 Aeglea BioTherapeutics Provides Update on AEB1102 Clinical Program in Rare Diseases and Cancer
19 Jul 2016 Hansa Medical Initiates Pivotal Multicenter Study in the US with IdeS for Treatment of Refractory Highly Sensitized Kidney Patients
18 Jul 2016 U.S. FDA Approves CSL Behring's Berinert® as the First and Only Pediatric Treatment for Hereditary Angioedema (HAE)
18 Jul 2016 Pharming Announces Positive Results from Randomized Controlled Trial with RUCONEST® for HAE Prophylaxis
15 Jul 2016 Ultragenyx Announces Positive Topline Data from Phase 3 Study of Recombinant Human Beta-Glucuronidase in Mucopolysaccharidosis Type 7
14 Jul 2016 Panther Biotechnology Announces the Initiation of Formal Development of Transferrin Doxorubicin Conjugate
14 Jul 2016 Alexion Presents New SBC-103 (rhNAGLU enzyme) Phase 1/2 Data on Brain MRI and Neurocognitive Assessments in Patients with Mucopolysaccharidosis IIIB (MPS IIIB)
11 Jul 2016 Coherus Announces Positive Topline Results for CHS-1701 (Pegfilgrastim Biosimilar Candidate) Pharmacokinetic and Pharmacodynamic Biosimilarity Study
07 Jul 2016 Akari Therapeutics Announces Positive Interim Update from Phase Ib Trial Demonstrating Sustained Complement Inhibition Using Once-Daily Subcutaneous Maintenance Dosing with Coversin
07 Jul 2016 Shire Receives Extension of Market Authorization in Europe for Revestive▼ (Teduglutide) for the Treatment of Paediatric Patients with Short Bowel Syndrome (SBS)
07 Jul 2016 Sanofi Genzyme Begins Pivotal Phase 2/3 Trial of Olipudase Alfa for Adult Patients with Acid Sphingomyelinase Deficiency
06 Jul 2016 Cinfa Biotech announces positive top-line clinical data of pegfilgrastim biosimilar candidate B12019
04 Jul 2016 European Commission Approves Extended Indication For Amgen's Kyprolis® (Carfilzomib) For The Treatment Of Relapsed Multiple Myeloma Patients
30 Jun 2016 Shire Announces Top-Line Results for Phase 2 Trial of SHP607 in Extremely Premature Infants
29 Jun 2016 Aurinia Announces 24 Week Remission Rates from the First Seven Patients in its Open Label AURION Study in Lupus Nephritis (LN)
28 Jun 2016 Glide Technologies Announces Successful Clinical Proof-of-Concept Study with its Novel Octreotide Solid Dose Formulation Delivered via SDI
27 Jun 2016 Tarix Orphan Announces Positive Results with TXA127 in Animal Model of Dystrophic Epidermolysis Bullosa (DEB)
27 Jun 2016 Stealth BioTherapeutics Initiates Two Phase 2 Trials Evaluating Elamipretide for the Treatment of Heart Failure
23 Jun 2016 Apellis Announces Positive Results from Phase 1 Clinical Trials of APL-2, a C3 Complement Inhibitor
23 Jun 2016 Angiochem Announces Successful End-of-Phase 2 Meeting With FDA for ANG1005
22 Jun 2016 AntriaBio Announces Preclinical Proof of Concept for Once-Weekly Basal Insulin AB101 in Diabetic Miniature Swine
22 Jun 2016 Cytonics Announces That Its Recombinant A2M Variants Attenuate Cartilage Degeneration in OA Models
17 Jun 2016 Auris Medical Initiates ASSENT Phase 3 Trial of AM-111 for Treatment of Sudden Deafness

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing